Persistent Presence of Postoperative Circulating Tumor Cells is a Poor Prognostic Factor for Patients with Stage I–III Colorectal Cancer after Curative Resection
- 15 May 2008
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 15 (8) , 2120-2128
Abstract
To detect pre- and postoperative circulating tumor cells (CTCs) in stage I–III colorectal cancer (CRC) patients undergoing curative resection and so identify a subgroup of patients who are at high risk for relapse. Four mRNA molecular markers including human telomerase reverse transcriptase, cytokeratin-19, cytokeratin-20, and carcinoembryonic antigen mRNA were used to detect CTCs in 438 CRC patients underwent curative resection. Out of 438 patients, 80 CRC patients were classified to preoperative (−)/postoperative (−), 221 patients were preoperative (+)/postoperative (−), while 137 patients were preoperative (+)/postoperative (+). Univariately, postoperative relapse was significantly correlated with depth of invasion (P = 0.032), lymph node metastasis (P < 0.001), vascular invasion (P = 0.001), perineural invasion (P = 0.013), and persistent presence of CTCs (P < 0.001). Using a multivariate proportional hazards regression analysis, the presence of lymph node metastasis (P = 0.012; HR, 7.652; 95% CI: 4.162–14.827), vascular invasion (P = 0.033; HR, 4.360; 95% CI: 2.793–10.847), and the persistent presence of CTCs (P < 0.001; HR, 29.486; 95% CI: 10.281–87.792) were demonstrated to be independent predictors for postoperative relapse. Combination of these three independent predictors showed that patients with any one positive predictor had a hazard ratio of sevenfold to develop postoperative relapse (P < 0.001; HR, 7.064; 95% CI: 4.354–11.464). Furthermore, the persistent presence of CTCs was strongly correlated with poorer relapse-free survival rates (all P < 0.001). The promising results of this study suggest that persistent presence of postoperative CTCs may be a crucial prognostic factor adjuvant to conventional tumor markers in CRC patients who have undergone curative resection. Identification of these high-risk patients of persistent CTCs positivity is important and thus could help to define patients for adjuvant therapy with this tumor entity.Keywords
This publication has 28 references indexed in Scilit:
- Epithelial Molecular Markers in the Peripheral Blood of Patients with Colorectal CancerDiseases of the Colon & Rectum, 2007
- Detection of Carcinoembryonic Antigen Messenger RNA-Expressing Cells in Peripheral Blood 7 Days After Curative Surgery is a Novel Prognostic Factor in Colorectal CancerAnnals of Surgical Oncology, 2007
- Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinomaBritish Journal of Surgery, 2007
- Development of a high‐throughput membrane‐array method for molecular diagnosis of circulating tumor cells in patients with gastric cancersInternational Journal of Cancer, 2006
- Detection of circulating cancer cells with K-ras oncogene using membrane arrayCancer Letters, 2005
- Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancerBritish Journal of Surgery, 2003
- Disseminated Single Tumor Cells as Detected by Real-Time Quantitative Polymerase Chain Reaction Represent a Prognostic Factor in Patients Undergoing Surgery for Colorectal CancerAnnals of Surgery, 2002
- Micrometastases and Survival in Stage II Colorectal CancerNew England Journal of Medicine, 1998
- Value of postoperative surveillance after radical surgery for colorectal cancerDiseases of the Colon & Rectum, 1998
- American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal CancerCA: A Cancer Journal for Clinicians, 1997